Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

0(0%)

Results Posted

50%(3 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_1

57%

Ph phase_3

29%

Ph phase_2

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

4(57.1%)

Phase 2Efficacy & side effects

1(14.3%)

Phase 3Large-scale testing

2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(1)

Detailed Status

Completed6

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 3

Trials by Phase

Phase 14 (57.1%)

Phase 21 (14.3%)

Phase 32 (28.6%)

Trials by Status

terminated114%

completed686%

Recent Activity

0 active trials

Showing 5 of 7

terminatedphase_1

Oxytocin Aging Study

NCT02069431

completedphase_3

Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study

NCT03339024

completedphase_1

Clinical Trials (7)

Showing 7 of 7 trials

NCT02069431Phase 1

Oxytocin Aging Study

Terminated

NCT03339024Phase 3

Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study

Completed

NCT02548728Phase 1

Oxytocin Treatment of Opioid Dependence

Completed

NCT02903251Phase 3

Oxytocin and Alcohol Withdrawal and Dependence

Completed

NCT02275611Phase 2

Oxytocin Treatment of Alcohol Dependence

Completed

NCT01394471Phase 1

Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia

Completed

NCT01212185Phase 1

Oxytocin Treatment of Alcohol Withdrawal

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7